Fundraising Fox
Dare Bioscience
NASDAQ: DARESan Diego, US · Delaware corporation · 3 known investors
Find your way into Dare Bioscience
Sign up to see every warm intro you have to Dare Bioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dare Bioscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Daré Bioscience is a female-led biotech company developing treatments for women's health conditions that are overlooked in the healthcare industry. The company uses rigorous clinical trial methods and evidence-based research to bring FDA-approved and pipeline therapeutics to patients through both traditional regulatory pathways and compounding services.
Founders & leadership
MH
MarDee Haring-LaytonChief Accounting OfficerMarDee Haring-Layton is Chief Accounting Officer at Daré Bioscience, a biotech company developing treatments for overlooked women's health conditions. She brings over 20 years of accounting and finance experience, including Big 4 audit work, with expertise in SEC reporting, financial analysis, internal audit, and Sarbanes-Oxley compliance.
SM
Sabrina Martucci JohnsonFounder & Chief Executive Officer
CD
Christopher D.T. GuiffreExecutive
GB
Gregg BeloffExecutive
AV
Alejandra V. CarvajalExecutive
AS
Adrian SenderowiczExecutive
Board
AL
JG
Jessica GrossmanBoard director
WH
William H. RastetterBoard director
RS
Robin SteeleBoard director
SL
Susan L. KelleyBoard director
GW
Gregory W. MatzBoard director
Investors · 3
Lilly Venturesreported
How we know: the S-1 prospectus · Not right? Tell us
Polaris PartnersinferredBoston · $500K – $5Mvia Alan Crane · board
How we know: board seat on SEC Form D · Not right? Tell us
VenrockreportedPalo Alto · $500K – $10M
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$38.3M disclosed across 5 of 6 rounds · 2016–2026
▶$12.4MraisedAug 2026 · 12 investors · BiotechnologyRule 506(b)
▶$12.4MraisedAug 2026 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sabrina Martucci JohnsonExecutive Officer, Director
- MarDee Haring-LaytonExecutive Officer
- William H. RastetterDirector
- Jessica D. GrossmanDirector
- Susan L. KelleyDirector
- Gregory W. MatzDirector
- Robin J. SteeleDirector
- Offering amount
- $12.4M
- Amount sold
- $12.4M
- Placement agents
- Ladenburg Thalmann & Co. Inc.
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MofferedNov 2024 · 1 investors · BiotechnologyRule 506(b)
▶$15MofferedNov 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MarDee Haring-LaytonExecutive Officer
- Jessica GrossmanDirector
- William H. RastetterDirector
- Robin SteeleDirector
- Susan L. KelleyDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Gregory W. MatzDirector
- Offering amount
- $15M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedDec 2023 · 1 investors · BiotechnologyRule 506(b)
▶$1.7MraisedDec 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sophia N. Ononye-OnyiaDirector
- Jessica D. GrossmanDirector
- Cheryl R. BlanchardDirector
- Susan L. KelleyDirector
- Robin J. SteeleDirector
- Lisa Walters-HoffertExecutive Officer
- William H. RastetterDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Gregory W. MatzDirector
- Offering amount
- $4.2M
- Amount sold
- $1.7M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedSep 2021 · 28 investors · BiotechnologyRule 506(b)
▶$3.5MraisedSep 2021 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robin J. SteeleDirector
- Susan L. KelleyDirector
- Lisa Walters-HoffertExecutive Officer
- Jessica D. GrossmanDirector
- Cheryl BlanchardDirector
- William H. RastetterDirector
- Gregory W. MatzDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.7MraisedJul 2017 · 18 investors · BiotechnologyRule 506(b)
▶$20.7MraisedJul 2017 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robin J. SteeleDirector
- Lisa Walters-HoffertExecutive Officer
- Roger L. HawleyDirector
- William H. RastetterDirector
- Susan L. KelleyDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Offering amount
- $20.7M
- Amount sold
- $20.7M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1raisedOct 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$1raisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christopher D.T. GuiffreExecutive Officer, Director
- Gregg BeloffExecutive Officer
- Alejandra V. CarvajalExecutive Officer
- Adrian SenderowiczExecutive Officer
- David R. ParkinsonDirector
- William H. RastetterDirector
- William T. McKeeDirector
- Alan L. CraneDirector
- Susan L. KelleyDirector
- David WaltDirector
- Stuart A. ArbuckleDirector
- Paul A. FriedmanDirector
- Offering amount
- $1
- Amount sold
- $1
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$157.3Mvaluation at IPOApr 2015 · $6.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 6
AlloyAlloy is a telehealth service that connects women in midlife and menopause with board-certified, menopause-trained doctors for treatments including hormone therapy, GLP-1 weight care, skincare, sexual health, hair and gut health. It offers online intake, ongoing messaging with physicians, and cash-pay/FSA-HSA-eligible prescription products.
VellabioVella Bioscience develops products for women's sexual and reproductive health using nano-encapsulated liposomal cannabidiol and liposome-based biotech to improve absorption of active ingredients, with a focus on female arousal, orgasm, and related pain. Its work spans the broader landscape of women's sexual and reproductive medicine.
EvernowEvernow provides personalized, longitudinal menopause care for women, offering access to menopause providers, treatments, and ongoing support. It operates as a telehealth service in the U.S. focused on women's health during the menopause transition.
HoneHone is an online clinic offering telehealth consultations, doctor-prescribed medications, and biomarker testing to help aging men and women manage their health. It provides personalized, proactive care aimed at Americans seeking to improve health and longevity.
WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Midi HealthMIDI develops digital health solutions for patients and clinicians to improve access to and delivery of care across diverse populations. The company takes an experimental approach to building tools that address unmet clinical needs.
Companies working in the same space as Dare Bioscience.
Frequently asked questions
- What does Dare Bioscience do?
- Daré Bioscience is a female-led biotech company developing treatments for women's health conditions that are overlooked in the healthcare industry. The company uses rigorous clinical trial methods and evidence-based research to bring FDA-approved and pipeline therapeutics to patients through both traditional regulatory pathways and compounding services.
- Who are Dare Bioscience's investors?
- Dare Bioscience's investors include Lilly Ventures, Polaris Partners, Venrock.
- How much funding has Dare Bioscience raised?
- Dare Bioscience has disclosed $38.3M raised across 5 of its 6 known rounds.
- Where is Dare Bioscience headquartered?
- Dare Bioscience is headquartered in San Diego, US.